TREM1 and glioma: Following this, they developed a nomogram utilizing the TREM1 expression level, WHO grade, gender, age, radiotherapy, chemotherapy, and IDH status, sourced from the TCGA cohort, to forecast the 1-year, 3-year, and 5-year survival probabilities of glioma patients.